STOCK TITAN

Argus - Real-Time Stock Momentum Scanner Beta v0.15.5

Argus helps you stay on top of significant stock market movements by automatically tracking stocks making new highs and lows, while gathering relevant news, instantly correlating these movements with breaking news to give you the complete picture of market action as it happens. This tool operates during pre-market, market hours, and after hours. Perfect for traders who want to understand market dynamics at a glance.

Stay updated with the top gainers and losers of the day, including news links that explain the reasons behind these movements.

Free Access: Updates every minute with approximated data for general market overview.

Gold Members: Real-time updates with enhanced accuracy and additional data. Upgrade to Gold

Alerts

In the table below, you'll find alerts on hot stocks making new highs or new lows. Each alert includes the stock symbol, number of triggers today, price changes, and relevant news links when available.

Market Cap:
  • 0-100M
  • 100-200M
  • 200M-1B
  • 1-10B
Float:
  • 0-10M
  • 10-50M
  • 50-100M
  • 100-200M
Volume:
  • 50K-100K
  • 100K-250K
  • 250K-500K
  • >500K
Rel.Volume:
  • 1x-2x
  • 2x-4x
  • 4x-8x
  • >8x

Filters


News Gold

Display only stocks with recent news. Use this to focus on stocks influenced by the latest events or announcements, filtering out those with no recent updates.

Gold Membership Required

Use this filter to determine if you want to see stocks going up or stocks going down.

Movement Gold

Filter by stock movement. Select 'Gainers' to view rising stocks or 'Losers' for declining stocks. Define minimum and maximum price change percentages to refine your search based on movement magnitude.

%
%
%
%

Gold Membership Required

Use this filter to determine if you want to see stocks going up or stocks going down.

Alerts Gold

Set a range for the number of alerts. A higher minimum shows stocks with frequent alerts, indicating strong activity; a lower maximum displays stocks with recent alerts for early detection.

Gold Membership Required

This filter permits you to set a specific range or limits for the alerts sent on the table.

Stock Price Gold

Specify a stock price range to narrow results. Input a minimum and maximum price to focus on stocks within your preferred price bracket, ideal for finding specific segments like penny stocks.

$
$

Gold Membership Required

This filter permits you to set a specific range for stock prices.

By inputting a minimum and maximum price, the feature only displays news associated with stocks within your defined bracket.

It's particularly beneficial when searching for stocks within a distinct price range, for example penny stocks.

Market Cap Gold

Set a range for market capitalization to find companies of a certain size. This filter helps you focus on stocks with specific market values, ranging from small to large-cap companies.

$Millions
$Millions

Gold Membership Required

This filter lets you define a range for a company's market capitalization or 'Market Cap', which is the total market value of a company's outstanding shares of stock.

By setting a minimum and maximum market cap (expressed in millions of dollars), the filter helps you focus on news related to stocks within a specific market capitalization range.

Float Gold

Define a range for stock float, the number of shares available for trading. A lower float often means higher volatility, while a higher float can indicate stability. Values are indicated in millions.

Millions
Millions

Gold Membership Required

This filter enables you to define a range for the number of shares available for trading, referred to as the 'Float'.

A minimum and maximum value can be set.

This feature is beneficial when searching for stocks with a specific level of liquidity or quantity of shares available for trading, often related with the stock price volatility.

The filter's values are expressed in millions.

Volume & 5min Delta Gold

Filter by Volume (total shares traded, relative to monthly average) and 5-minute delta (price change % and volume relative to weekly average in the last 5 min). Set min/max values.

shares
shares
x
x

x
x

Gold Membership Required

Set ranges for volume (shares traded), relative volume (compared to monthly average), 5-minute price change (%), and 5-minute relative volume (compared to weekly average).

Use these filters to find stocks with specific liquidity levels, unusual trading activity, or recent short-term momentum shifts.

Higher relative volumes indicate unusual activity. 5-minute deltas highlight rapid price/volume changes.

Time Symbol Change% News Price Mkt Cap Float Volume RVol (M) RVol (W) 5min Δ% 5min Vol
07:32:16 PM PHVS new -4.00% - 928.56M 34.66M 39.99K 0.35x
07:32:16 PM MHUA new 9.00% - 8.71M 15.97M 208.75K 0.58x
07:32:21 PM CSCI x2 -6.00% - 10.63M 3.1M 5.51K 1.6x
07:32:52 PM GTI x3 -4.00% - 16.04M 71.27M 1.06M 0.69x
07:32:59 PM ITP x3 -5.00% - 2.73M 9.52M 305.26K 2.68x
07:33:06 PM OCTO x2 -6.00% - 4.13M 2.77M 87.88K 0.55x
07:33:53 PM XHG x2 6.00% - 1.69M 19.99M 2.73M 0.83x
07:34:22 PM ABP new 7.00% - 10.04M 22.31M 2.26M 3.23x
07:35:08 PM CTMX x14 17.00% - 87.88M 79.7M 5.96M 3.39x
07:35:16 PM MI x3 -6.00% - 14.79M 4.33M 101.2K 4.89x
07:35:56 PM DHX x6 -5.00% Quarterly earnings report
84M 40.89M 511.44K 4x
07:36:18 PM SLE x2 5.00% Cost Cutting Measures
Earnings Announcement Scheduled
5.84M 12.15M 154.16K 2.13x
07:36:29 PM HEPA new 4.00% Diagnostic Tests Commercialization
4.31M 10.91M 2.21M 0.48x
07:36:29 PM CTMX x15 18.00% - 87.88M 79.7M 5.96M 3.39x
07:36:38 PM RNAZ x3 5.00% Clinical trial progress
8.17M 23.31M 2.93M 0.29x
07:36:38 PM GEOS x3 -13.00% Quarterly Earnings Report
85.09M 11.72M 40.54K 0.8x
07:36:49 PM ALTI new 4.00% - 328.58M 42.04M 72.24K 0.96x
07:37:59 PM MKZR new 5.00% - 16.93M - 59.35K -
07:38:11 PM PRFX x3 -6.00% Solar project optimization
3.66M 1.68M 3.01M 0.73x
07:38:31 PM REPL x4 9.00% - 598.4M 72.42M 1.09M 0.99x
07:38:35 PM AYRO x5 6.00% - 4.33M 5.9M 665.68K 7.08x
07:38:46 PM CLDI x2 6.00% - 11.81M 26.29M 295.69K 1.27x
07:38:52 PM PHLT x4 13.00% Quarterly earnings report
176.19M 69.23M 123.29K 0.96x
07:39:12 PM CTMX x16 19.00% - 87.88M 79.7M 5.97M 3.4x
07:39:18 PM RNAZ x4 7.00% Clinical trial progress
8.17M 23.31M 2.94M 0.29x
07:40:58 PM TRVI new 5.00% Financial results update
671.52M 75.04M 1.27M 0.96x
07:41:02 PM NTHI x3 -7.00% - 123.72M 2.1M 317.9K 4.13x
07:41:08 PM GDOT x7 21.00% Quarterly earnings report
477.4M 53.01M 948.51K 1.42x
07:41:26 PM PRME new 6.00% Financial results update
173.13M 99.56M 2.3M 1.51x
07:41:43 PM SLXN new -4.00% - 8.64M 8.06M 189.87K 0.05x
07:41:48 PM MCHP x3 7.00% Quarterly dividend announced
Earnings Report Released
26.43B 526.5M 11.27M 0.91x
07:41:55 PM RNAZ x5 8.00% Clinical trial progress
8.17M 23.31M 2.94M 0.29x
07:43:21 PM NRSN new -5.00% Manufacturing scale-up completed
25.19M 16.56M 69.21K 0.66x
07:43:21 PM YCBD x3 -4.00% Distribution Agreement Expansion
673.25K 674.88K 214.76K 2.04x
07:43:21 PM STTK new -4.00% - 45.01M 41.01M 79.2K 0.63x
07:43:21 PM OLB new -5.00% - 3.32M 1.69M 78.19K 0.04x
07:43:21 PM DRMA x2 -4.00% - 4.89M 4.61M 113.83K 0.4x
07:43:21 PM ZBAI x2 -4.00% - 16.11M 12.03M 21.31K 0.16x
07:43:21 PM MODV x3 -12.00% Quarterly earnings report
19.37M 11.99M 430.24K 0.86x
07:43:34 PM CETY x5 9.00% - 21.42M 20.86M 910.69K 11.48x
07:43:45 PM GPCR new -5.00% Earnings report released
1.54B 52.94M 609.1K 0.52x
07:43:57 PM CETY x6 10.00% - 21.42M 20.86M 923.77K 11.64x
07:44:02 PM CLDI x3 10.00% - 11.81M 26.29M 296.67K 1.28x
07:44:29 PM IPDN new 4.00% - 3.65M 1.05M 13.15K 0.12x
07:44:55 PM HKPD x2 -4.00% - 9.79M 1.4M 118.75K 0.5x
07:44:58 PM PNBK new -4.00% - 316.28M 57.81M 180.6K 0.71x
07:45:59 PM TIVC new 4.00% - 2.57M 618.92K 47.29K 0.02x
07:47:10 PM CETY x8 15.00% - 21.42M 20.86M 935.92K 11.8x
07:47:26 PM GTI x4 -5.00% - 16.04M 71.27M 1.06M 0.69x
07:47:45 PM TIVC x2 5.00% - 2.57M 618.92K 86.47K 0.04x
07:47:51 PM PACK x2 5.00% - 282.18M 76.94M 1.1M 1.76x
07:48:12 PM FFAI x2 -4.00% AI Hybrid Patents
Quarterly earnings report
116.93M 87.85M 7.1M 0.77x
07:49:29 PM SVRA new -4.00% - 556.25M 154.84M 1.34M 2.16x
07:49:34 PM ZOOZ x2 -23.00% - 17.64M 8.5M 20.28K 1.04x
07:49:39 PM ELWS x3 -7.00% Nasdaq delisting appeal
5.58M 1.12M 19.25K 0.76x
07:50:02 PM MTNB x3 4.00% - 3.56M 4.67M 80.85K 2.06x
07:50:02 PM SPWH new -4.00% - 69.68M 37.27M 282.01K 0.68x
07:50:51 PM PROK new 7.00% - 204.89M 90.5M 531.04K 0.45x
07:52:02 PM ALTS new -7.00% - 97.44M 15.33M 110.92K 0.74x
07:52:04 PM SDM x2 -9.00% - 160.59M 1.5M 154.25K 0.12x
07:53:50 PM CMPX new -6.00% Quarterly earnings update
246.14M 94.17M 611.16K 0.82x
07:54:10 PM ISOU new -6.00% - 318.82M 13.14M 28.2K 0.64x
07:54:14 PM OP new -5.00% - 5.48M 1.6M 5.81K 0.23x
07:54:16 PM CTMX x17 21.00% - 87.88M 79.7M 6.07M 3.46x
07:54:36 PM XIN new -4.00% - 14.65M 5.61M 13.26K 0.26x
07:54:36 PM SGLY new 4.00% - 4.46M 4.2M 109.69K 1.13x
07:55:00 PM TOPW new -4.00% - 101.94M 2.66M 188.56K 0.53x
07:55:00 PM IOTR x4 4.00% Maritime digital solutions
11.73M 2.63M 1.23M 0.73x
07:55:04 PM CTMX x18 22.00% - 87.88M 79.7M 6.08M 3.46x
07:55:17 PM TOPW x2 -6.00% - 101.94M 2.66M 188.58K 0.53x
07:55:25 PM FAAS new -4.00% - 12.29M 26.64M 195.37K 0.31x
07:55:31 PM PTHL x3 -4.00% - 66.26M 2.25M 352.22K 1.81x
07:55:52 PM CTMX x20 23.00% - 87.88M 79.7M 6.09M 3.47x
07:55:56 PM CTMX x21 25.00% - 87.88M 79.7M 6.09M 3.47x
07:56:09 PM GPUS new 4.00% - 52.95M 1.7M 45.35M 2.05x
07:56:49 PM CTMX x22 26.00% - 87.88M 79.7M 6.1M 3.47x
07:57:03 PM DTST new -4.00% - 25.96M 4.12M 12.75K 0.67x
07:57:04 PM FFAI x3 -5.00% AI Hybrid Patents
Quarterly earnings report
116.93M 87.85M 7.17M 0.78x
07:57:34 PM CTMX x23 27.00% - 87.88M 79.7M 6.11M 3.48x
07:58:44 PM PRFX x4 -7.00% Solar project optimization
3.66M 1.68M 3.01M 0.73x
07:58:45 PM CLEU new 4.00% - 6.3M 3.32M 19.18K 0.59x
07:59:01 PM OXBR new -4.00% - 10.72M 6.25M 39.39K 0.42x
07:59:23 PM TOPW x3 -9.00% - 101.94M 2.66M 189.64K 0.53x
07:59:23 PM PTHL x4 -5.00% - 66.26M 2.25M 352.42K 1.81x
07:59:33 PM MDIA new 4.00% Multicultural media expansion
42.92M 40.34M 31.89K 0.9x
07:59:33 PM CTMX x24 28.00% - 87.88M 79.7M 6.15M 3.5x
07:59:41 PM NVNO x2 5.00% - 63.66M 17.35M 114.41K 1.45x
07:59:43 PM DYAI new 7.00% - 32.5M 21M 48.37K 1.36x
07:59:44 PM LHSW new -4.00% - 161.2M 2M 383.86K 0.88x
07:59:46 PM CETY x11 16.00% - 21.42M 20.86M 958K 12.08x
07:59:59 PM GRYP new 5.00% - 28.28M 44.87M 2.61M 1.96x
07:59:59 PM CAMP x3 -6.00% - 43.14M 11.81M 291.61K 0.42x

Top Gainers

WORX:NASDAQ
Change +87.00 %
Market Cap 1.15M
Float 2.02M
Volume 10.01M
ZKIN:NASDAQ
Change +61.00 %
Market Cap 13.01M
Float 3.76M
Volume 90.54M
CRVS:NASDAQ
Change +47.00 %
Market Cap 228.37M
Float 52.6M
Volume 4.71M

Why is CRVS stock up?

On May 08, Corvus Pharmaceuticals reported positive interim Phase 1 data for soquelitinib in moderate to severe atopic dermatitis. The 200mg BID cohort showed a 71.1% mean EASI reduction vs 42.1% for placebo, with no dose-limiting toxicities and strong biomarker reductions. The protocol was amended to enroll 24 more patients at the highest dose, with a Phase 2 trial planned by year-end.

Also on May 08, Corvus announced Q1 2025 financials with a $44.2 million cash position, $31.3 million from warrant exercises at $3.50 per share, and net income of $15.2 million (including a $25.1 million warrant liability gain). R&D expenses rose to $7.5 million from $4.1 million in Q1 2024.

WBUY:NASDAQ
Change +35.00 %
Market Cap 5.55M
Float 301.21K
Volume 1.59M

Why is WBUY stock up?

Webuy Global (WBUY) surged after announcing on May 8 its reinstatement to the Nasdaq Capital Market effective May 8, 2025 following a successful appeal and compliance with minimum bid price via reverse splits.

  • Q1 2025 travel revenue in Indonesia soared to US$1.25 million (2,160% YoY growth).
  • Travel bookings at the NATAS Fair in Singapore hit US$2.6 million (45% YoY increase).
  • First group-level profit achieved in Q4 2024; company plans to scale high-margin verticals and expand its AI-powered platform in Southeast Asia.
CTMX:NASDAQ
Change +27.00 %
Market Cap 87.88M
Float 79.7M
Volume 6.15M
BSGM:NASDAQ
Change +22.00 %
Market Cap 43.41M
Float 19.41M
Volume 1.81M
SHPH:NASDAQ
Change +22.00 %
Market Cap 1.69M
Float 4.7M
Volume 9.48M

Why is SHPH stock up?

Shuttle Pharmaceuticals (SHPH) is moving following a May 08 update that its Phase 2 trial for Ropidoxuridine, an FDA Orphan Drug for glioblastoma, has reached nearly 50% enrollment. The drug is well-tolerated with 84% of patients completing all seven cycles. The study targets 40 patients, with 14 more to be added at the optimal dose across six major centers, and data readout expected in 2026. The addressable US market is estimated at $400,000 patients annually, projected to grow 22% in five years.

GDOT:NYSE
Change +21.00 %
Market Cap 477.4M
Float 53.01M
Volume 948.52K

Why is GDOT stock up?

On May 8, Green Dot (GDOT) reported strong Q1 2025 results: total operating revenues rose 24% to $558.9M, net income jumped 443% to $25.8M, and diluted EPS was $0.47, up 422% YoY. The company announced new partnerships with Samsung and Crypto.com, renewed a major retail relationship, and raised 2025 guidance, now expecting non-GAAP revenues of $2.0B-$2.1B and non-GAAP EPS of $1.14-$1.28.

ZAPP:NASDAQ
Change +20.00 %
Market Cap 2.46M
Float 6.66M
Volume 90.78M
PHX:NYSE
Change +18.00 %
Market Cap 135.76M
Float 29M
Volume 147.72K

Why is PHX stock up?

PHX Minerals surged after announcing on May 8 a definitive agreement to be acquired by WhiteHawk Income Corporation in an all-cash deal valued at $4.35 per share, totaling approximately $187 million including net debt. This acquisition price is a key driver of the current stock movement.

  • Q1 2025 results: Net income of $4.4 million ($0.12 per share) versus a net loss in Q1 2024.
  • Adjusted EBITDA rose to $6.2 million from $4.6 million year-over-year.
  • Quarterly dividend of $0.04 per share payable June 4, 2025.
LASR:NASDAQ
Change +16.00 %
Market Cap 425.67M
Float 47.51M
Volume 332.11K

Why is LASR stock up?

nLIGHT (LASR) is moving after announcing on May 8 strong Q1 2025 results, with revenue up 16% year-over-year to $51.7 million, driven by record aerospace and defense performance. Gross margin rose sharply to 26.7% from 16.8% last year, and net loss narrowed to $8.1 million versus $13.8 million in Q1 2024. Q2 2025 revenue is guided between $53-59 million, and management forecasts at least 25% growth in aerospace and defense for 2025.

RSSS:NASDAQ
Change +16.00 %
Market Cap 91.74M
Float 27.04M
Volume 99.34K

Why is RSSS stock up?

On May 8, Research Solutions (NASDAQ: RSSS) posted strong fiscal Q3 2025 results, reporting total revenue of $12.7 million (+4.5% YoY), a 22% jump in platform revenue to $4.8 million, and a 23% rise in ARR to $20.4 million. Net income reached $216,000 ($0.01 per diluted share), with record Adjusted EBITDA of $1.4 million. Gross margin expanded by 430 basis points to 49.5%, and operational cash flow hit a record $2.9 million. Significant growth was noted in AI-based B2B offerings (+180% YoY).

PINS:NYSE
Change +15.00 %
Market Cap 18.84B
Float 589.27M
Volume 27.6M

Why is PINS stock up?

Pinterest surged after releasing Q1 2025 results on May 8, reporting $855 million in revenue (16% year-over-year growth) and a record 570 million global MAUs (10% increase). GAAP net income hit $9 million and Adjusted EBITDA reached $172 million with a 20% margin. Q2 2025 revenue guidance was set at $960-980 million, projecting 12-15% growth.

TMDX:NASDAQ
Change +14.00 %
Market Cap 3.15B
Float 32.82M
Volume 2.22M

Why is TMDX stock up?

On May 8, TransMedics (TMDX) reported a strong Q1 2025 with revenue of $143.5 million (+48% YoY), net income of $25.7 million ($0.70 per diluted share), and a gross margin of 61%. The company also raised full-year revenue guidance to $565-585 million (+30% at midpoint) and ended the quarter with $310.1 million in cash.

  • Growth driven by increased OCS utilization, especially in Liver and Heart transplants through the National OCS Program.
  • Announced plans for a new design center and manufacturing facility in Italy.
BUJA:NASDAQ
Change +14.00 %
Market Cap 18.09M
Float 3.06M
Volume 342.34K

Why is BUJA stock up?

BUJA is moving on news from May 8 that Global IBO Group Ltd. has completed its business combination with Bukit Jalil Global Acquisition 1 Ltd. (BUJA). The new entity, serving over 72 million registered users across Southeast Asia and South Asia, will begin trading on Nasdaq as "GIBO" and "GIBOW" starting May 9, 2025. The merger, approved on March 31, 2025, positions GIBO as an integrated AIGC animation streaming platform offering AI-powered tools for content creation.

PHLT:NASDAQ
Change +13.00 %
Market Cap 176.19M
Float 69.23M
Volume 123.29K

Why is PHLT stock up?

On May 08, Performant Healthcare (NASDAQ: PHLT) posted strong Q1 2025 results: total revenue rose 22% year-over-year to $33.3M, with healthcare revenue up 29% to $33.2M. Net loss narrowed sharply to $0.1M from $4.0M in Q1 2024. Claims-based revenue grew 38% to $17.1M, eligibility-based revenue rose 20% to $16.1M. Management raised full-year guidance to $133-135M healthcare revenues and $9-10M adjusted EBITDA.

DXST:NASDAQ
Change +13.00 %
Market Cap 19.66M
Float 1.5M
Volume 166.84K
SKIN:NASDAQ
Change +12.00 %
Market Cap 156.23M
Float 113.35M
Volume 929.38K

Why is SKIN stock up?

On May 8, BeautyHealth (NASDAQ: SKIN) announced Q1 2025 results: net sales of $69.6 million (down -14.5% YoY), gross margin rose to 69.8% from 59.4%, net loss widened to $10.1 million, while Adjusted EBITDA improved to $7.3 million vs. $0.4 million last year. The active install base increased to 35,014 units. The company is shifting its China operations to a distributor model and updated FY2025 guidance to $270-300 million in net sales and $15-25 million in Adjusted EBITDA.

ASST:NASDAQ
Change +12.00 %
Market Cap 110.84M
Float 12.65M
Volume 241.92M

Why is ASST stock up?

Asset Entities (NASDAQ: ASST) is moving on news from May 7 of a definitive merger agreement with Strive Asset Management to form the first publicly traded asset management Bitcoin treasury company. The combined entity will operate under the Strive brand, stay NASDAQ-listed, and be led by CEO Matt Cole.

  • Post-merger, Strive Enterprises will own 94.2% and Asset Entities shareholders 5.8%.
  • Plans include a shelf registration expansion to $1 billion for Bitcoin accumulation via equity and debt offerings.
  • Strive Asset Management currently manages around $2B in assets.
  • Innovative strategies include a tax-free Bitcoin-for-stock exchange under Section 351 and acquiring cash at a discount through mergers.
AMN:NYSE
Change +12.00 %
Market Cap 776.62M
Float 37.84M
Volume 1.74M

Why is AMN stock up?

On May 8, AMN Healthcare reported Q1 2025 results with revenue of $690 million (down -16% YoY), a GAAP loss of ($0.03) per share, and adjusted EPS of $0.45. Key segments all declined YoY: Nurse and Allied Solutions $413M (-20%), Physician and Leadership Solutions $174M (-8%), Technology and Workforce Solutions $102M (-9%). Q1 results topped guidance, with strong operating cash flow at $93M and $60M debt reduction. Q2 2025 revenue guidance is $645-660M (-11 to -13% YoY).

ACET:NASDAQ
Change +11.00 %
Market Cap 39.57M
Float 69M
Volume 543.6K
PSIX:NASDAQ
Change +11.00 %
Market Cap 638.48M
Float 6.47M
Volume 327.14K

Why is PSIX stock up?

Power Solutions International released on May 08 its strongest first quarter ever, reporting Q1 2025 net sales of $135.4 million (up 42% YoY), net income of $19.1 million (168% increase), and EPS of $0.83 versus $0.31 last year. Gross margin rose to 29.7%. Growth was led by power systems, notably in data centers and oil and gas. The company also reduced debt by $10.0 million in Q1, ending with $111.0 million debt and $50.0 million cash as of March 31, 2025.

TTD:NASDAQ
Change +10.00 %
Market Cap 29.44B
Float 445.27M
Volume 26.5M

Why is TTD stock up?

On May 8, The Trade Desk posted Q1 2025 results with revenue up 25% YoY to $616 million, net income at $51 million (8% margin), and adjusted EBITDA of $208 million (34% margin). Customer retention stayed above 95% for the eleventh year. Q2 2025 guidance forecasts revenue of at least $682 million and adjusted EBITDA of $259 million.

  • Leadership update: Vivek Kundra appointed as COO.
  • Strategic moves: Sincera acquisition, expansion of Unified ID 2.0 and OpenPath partnerships.
  • Capital return: $386 million in Class A stock repurchases.
PMNT:AMEX
Change +10.00 %
Market Cap 15.29M
Float 12.49M
Volume 9.01K
CETY:NASDAQ
Change +10.00 %
Market Cap 21.42M
Float 20.86M
Volume 955K

Top Losers

IOVA:NASDAQ
Change -38.00 %
Market Cap 1.06B
Float 285.87M
Volume 26.67M

Why is IOVA stock down?

Iovance Biotherapeutics released Q1 2025 results on May 8, reporting $49.3M total revenue, including $43.6M from Amtagvi and $5.7M from Proleukin. The company lowered its FY25 revenue guidance to $250M-$300M, citing Q1 production disruptions due to scheduled maintenance, though operations have now resumed.

  • Cash position: $366M, expected to fund into 2H26.
  • Product reach: Over 275 Amtagvi patients treated, more than $210M in 12-month launch revenue.
  • Regulatory outlook: Amtagvi approval expected in UK, EU, Canada in 2025.

The reduction in annual guidance and Q1 production disruption are key drivers behind today's price action.

VEEE:NASDAQ
Change -36.00 %
Market Cap 11.08M
Float 1.12M
Volume 83.99M

Why is VEEE stock down?

Twin Vee PowerCats (NASDAQ:VEEE) announced a public offering of 750,000 shares at $4.00 per share on May 8, raising $3 million. This offering, priced below recent trading levels, is a clear dilution event and a common trigger for sharp downward moves as investors react to increased supply and a lower price anchor.

Earlier on May 8, the company reported $3.6 million in Q1 2025 revenues, up 91.7% from Q4 2024, with a gross margin improvement to 14.9% and a monthly adjusted net loss of $333,000. However, these positive results were overshadowed by the dilution news.

  • Offering size: 750,000 shares
  • Offering price: $4.00
  • Gross proceeds: $3 million
  • Revenue Q1 2025: $3.6 million (91.7% QoQ growth)
  • Gross margin: 14.9%
NCNA:NASDAQ
Change -35.00 %
Market Cap 584.63K
Float 5.67M
Volume 72M
ZOOZ:NASDAQ
Change -23.00 %
Market Cap 17.64M
Float 8.5M
Volume 20.28K
WOLF:NYSE
Change -19.00 %
Market Cap 689.18M
Float 154.06M
Volume 34.04M

Why is WOLF stock down?

Wolfspeed shares are reacting after the company reported Q3 FY2025 results on May 8: revenue fell to $185 million from $201 million year-over-year, and gross margins dropped sharply, with GAAP at -12% (from 11%), and non-GAAP at 2% (from 15%). Underutilization costs at Mohawk Valley Fab were $26.3 million.

  • Capital actions: Completed a $200 million ATM offering and received $192 million in Section 48D tax refunds.
  • Leadership: New CEO Robert Feurle is focusing on 200-mm capabilities and restructuring the capital base.
GMED:NYSE
Change -18.00 %
Market Cap 9.81B
Float 112.14M
Volume 1.84M

Why is GMED stock down?

Globus Medical released Q1 2025 results on May 8 with worldwide net sales of $598.1 million, a -1.4% year-over-year decline. U.S. net sales were up 0.2%, while international sales fell -7.7%. Challenges included softer Enabling Technology sales, temporary integration-related supply chain disruptions, and timing of international orders. The company became debt-free after paying off $450 million from the NuVasive merger and posted record Q1 free cash flow. Guidance for 2025 revenue was reaffirmed, but non-GAAP EPS guidance was lowered to $3.00–3.30 from $3.10–3.40 previously.

STI:NASDAQ
Change -18.00 %
Market Cap 21.41M
Float 68.29M
Volume 425.64M

Why is STI stock down?

Solidion Technology (NASDAQ:STI) shares are under pressure following the announcement on May 8 of newly secured patents for a process enabling existing lithium-ion battery factories to upgrade to solid-state battery production using an "in situ solidification" technique. The company targets full commercialization in 2-3 years, but the timeline and absence of immediate commercial deals may be seen as too long-term by the market, prompting profit-taking after prior speculative runs.

ORGO:NASDAQ
Change -18.00 %
Market Cap 677.4M
Float 67.49M
Volume 2.28M

Why is ORGO stock down?

Organogenesis Holdings Inc. posted Q1 2025 results on May 8 showing a net revenue drop to $86.7M (-21% YoY), with Advanced Wound Care down -23% and net loss widening to $18.8M from $2.1M last year. Operating expenses rose 5% to $89.7M with a $6.6M write-down.

The company reiterated its 2025 revenue guidance of $480-535M and reported $110.5M cash, no debt, and progress on the ReNu BLA submission, expected by end of 2025.

GDHG:NASDAQ
Change -17.00 %
Market Cap 9.15M
Float 3.82M
Volume 1.7M
RCEL:NASDAQ
Change -16.00 %
Market Cap 246.64M
Float 26.22M
Volume 219.12K

Why is RCEL stock down?

RCEL is reacting to its May 08 Q1 2025 results, where it reported $18.5 million in commercial revenue (+67% YoY) and a strong gross margin of 84.7%. Despite reaffirming full-year guidance and noting a successful product expansion, the company posted a net loss of $13.9 million ($0.53 per share), though improved from $18.7 million loss a year ago.

  • Launched RECELL GO mini™ and Cohealyx™, expanding its addressable U.S. market from $455 million to over $3.5 billion.
  • Guidance holds for $100-106 million revenue in 2025 (55-65% growth), with expected free cash flow in H2 and GAAP profitability in Q4.
RAIN:NASDAQ
Change -15.00 %
Market Cap 51.5M
Float 885.55K
Volume 30.41K
DEVS:NASDAQ
Change -15.00 %
Market Cap 9.82M
Float 13.99M
Volume 36.52M

Why is DEVS stock down?

On May 7, DevvStream Corp (NASDAQ: DEVS) announced a MoU with Fayafi Investment Holding to form a joint venture, "Fayafi x DevvStream Green Ventures", focused on global decarbonization and climate infrastructure projects. The JV will be 80% owned by Fayafi and 20% by DevvStream, with an initial funding commitment of $100 million. DevvStream will manage project identification and carbon credit management, while Fayafi handles capital and regulatory aspects. Final agreements are expected by Q2 2025, with project deployments in Q3/Q4 2025. The structure highlights a capital-light model for DevvStream, but only a minority ownership stake.

DYN:NASDAQ
Change -15.00 %
Market Cap 1.28B
Float 110.93M
Volume 7.12M

Why is DYN stock down?

Dyne Therapeutics released Q1 2025 results on May 8, reporting a sharp increase in R&D expenses to $106.4M (from $44.5M in Q1 2024) and a net loss of $115.4M ($1.05 per share). The company ended the quarter with $677.5M in cash, guiding operations into H2 2026.

Key updates include an FDA Type C meeting for DYNE-101 in DM1 and the start of a Registrational Expansion Cohort in the ACHIEVE trial, aiming for U.S. Accelerated Approval submission in H1 2026. The DELIVER trial for DYNE-251 in DMD is fully enrolled, with a BLA filing expected in early 2026. Leadership changes were also announced to support future launches.

SGBX:NASDAQ
Change -14.00 %
Market Cap 3.6M
Float 3.96M
Volume 1.88M
GRWG:NASDAQ
Change -13.00 %
Market Cap 73.17M
Float 54.97M
Volume 652.92K

Why is GRWG stock down?

GrowGeneration released its Q1 2025 financial results on May 08, reporting a sharp drop in net sales to $35.7 million from $47.9 million year-over-year, attributed mainly to the closure of 19 retail locations. Net loss widened to $9.4 million, despite improved gross profit margin of 27.2% and lower operating expenses. The company also withdrew full-year 2025 guidance citing macroeconomic uncertainty, but expects Q2 2025 revenue to exceed $40 million.

DCGO:NASDAQ
Change -12.00 %
Market Cap 230.91M
Float 92.05M
Volume 788.8K

Why is DCGO stock down?

DocGo released Q1 2025 results on May 08, reporting a sharp fall in revenue to $96.0 million from $192.1 million in Q1 2024 due to the wind-down of migrant-related programs. The company cut its 2025 revenue guidance to $300-$330 million from $410-$450 million and now expects an adjusted EBITDA loss of $20-$30 million. Net loss was $11.1 million compared to net income of $10.6 million last year. While Medical Transportation and Payer & Provider units showed solid performance, the overall outlook has deteriorated.

MODV:NASDAQ
Change -12.00 %
Market Cap 19.37M
Float 11.99M
Volume 430.24K

Why is MODV stock down?

Modivcare (MODV) is under pressure after releasing Q1 2025 financial results on May 08. The company reported service revenue of $650.7 million (-4.9% YoY), a net loss of $50.4 million ($3.52 per diluted share), and negative operating cash flow of $82.1 million. Segment performance was weak across the board: NEMT revenue -6.3%, PCS revenue -1.0%, and Monitoring revenue -9.8%. The company announced $105 million in new financing and plans for over $20 million in annualized G&A savings.

  • Q1 service revenue: $650.7M (-4.9% YoY)
  • Net loss: $50.4M ($3.52 per share)
  • Adjusted EBITDA: $32.6M (5.0% margin)
  • Negative operating cash flow: $82.1M
  • End-Q1 cash: $116.0M
PWM:NASDAQ
Change -11.00 %
Market Cap 12.12M
Float 6.27M
Volume 190.24K
LIDR:NASDAQ
Change -11.00 %
Market Cap 10.51M
Float 17.15M
Volume 7.83M

Why is LIDR stock down?

AEye (LIDR) shares are reacting to the May 08 Q1 2025 earnings report. The company posted a GAAP net loss of $(8.0) million ($(0.46) per share) and raised its 2025 cash burn outlook to $27-29 million from $25 million due to litigation and potential convertible note repayment. Cash and equivalents were $25.9 million at quarter-end.

  • Operationally, AEye marked the start of Apollo manufacturing at LITEON, expects B-sample deliveries in Q2 2025, and is finalizing NVIDIA DRIVE platform integration.

On May 07, AEye announced the production of its first Apollo lidar sensors with LITEON in Taiwan, a step forward in scaling manufacturing for automotive OEMs.

FIGS:NYSE
Change -10.00 %
Market Cap 820.72M
Float 145.99M
Volume 3.37M

Why is FIGS stock down?

FIGS is under pressure after its May 08 release of Q1 2025 results showed net revenues up 4.7% at $124.9 million, but a swing to net loss of $0.1 million from a $1.4 million profit last year. Gross margin fell 130 bps to 67.6%, and the 2025 outlook was revised to a low-single-digit revenue decline and adjusted EBITDA margin of 7.5%-8.5% due to U.S. tariff impacts.

GEOS:NASDAQ
Change -10.00 %
Market Cap 85.09M
Float 11.72M
Volume 40.75K

Why is GEOS stock down?

On May 8, Geospace Technologies (GEOS) reported Q2 2025 results showing a sharp revenue drop to $18.0 million from $24.3 million YoY and a net loss of ($9.8) million or ($0.77) per share. The Energy Solutions segment saw revenue plunge -76.5% to $2.6 million, hit by reduced marine node rental utilization and a $2.2 million revenue reversal over collectability concerns. The Intelligent Industrial segment was also down -12.8% YoY, while only the Smart Water segment posted strong growth, up +47.8% to $9.5 million. The company maintains $19.8 million in cash, no debt, and $14.9 million in available credit.

XNCR:NASDAQ
Change -10.00 %
Market Cap 625.42M
Float 70.3M
Volume 1.34M

Why is XNCR stock down?

May 07: Xencor (NASDAQ: XNCR) reported Q1 2025 results: revenue rose to $32.7M (from $16.0M last year), but net loss widened to $48.4M ($0.66 per share). Cash position remains strong at $693.5M. The XmAb942 Phase 1 study showed positive data, with Phase 2b planned for H2 2025. Chief Development Officer Nancy Valente will move to a senior advisory role in June 2025. Recent partnerships brought in milestone payments from Incyte ($12.5M) and Vir Biotechnology ($2.0M).

HROW:NASDAQ
Change -10.00 %
Market Cap 865.4M
Float 31.16M
Volume 1.01M

Why is HROW stock down?

Harrow's sharp move today follows its May 8 release of Q1 2025 results: revenue rose 38% year-over-year to $47.8 million, and flagship product VEVYE hit $21.5 million in sales, up 35% from last quarter. However, the company reported a GAAP net loss of $(17.8) million and negative Adjusted EBITDA of $(2.0) million, which may be raising concerns despite strong top-line growth and increased prescription volumes. Harrow reaffirmed its $280 million 2025 revenue target and ongoing acquisition strategy.

CNFR:NASDAQ
Change -10.00 %
Market Cap 9.03M
Float 6.9M
Volume 3.02K
KODK:NYSE
Change -10.00 %
Market Cap 541.13M
Float 62.77M
Volume 2.18M

Why is KODK stock down?

May 08: Kodak reported Q1 2025 results with revenue at $247 million (down from $249 million in Q1 2024), a GAAP net loss of $7 million versus net income of $32 million last year, and operational EBITDA dropping to $2 million from $4 million. Cash position fell to $158 million from $201 million at the end of 2024. The Print segment declined by $17 million, partly offset by a $15 million gain in Advanced Materials & Chemicals. The company is investing in a new cGMP facility for diagnostic test reagents and progressing with the termination of its KRIP U.S. pension plan.

What is Momentum Trading?

Momentum trading is a strategy that involves buying stocks that are rising and selling them when they look to have peaked. The idea is to capitalize on the continuance of existing trends in the market. Traders who use this strategy believe that stocks that have shown an upward price trend will continue to rise, and vice versa for declining values.

How Does Momentum Trading Work?

Momentum traders focus on stocks that are moving significantly in one direction on high volume. They try to ride the momentum wave until they see signs of reversal, at which point they exit the position. Key components include:

  • Trend Identification: Recognizing stocks that are moving sharply in one direction.
  • Volume Analysis: Ensuring that price movements are backed by substantial trading volume.
  • Timing the Market: Entering and exiting positions at optimal times to maximize profits.

Benefits of Momentum Trading

  • High Profit Potential: Capitalize on strong market movements for significant gains.
  • Short-Term Strategy: Suitable for traders who prefer not to hold positions long-term.
  • Clear Entry and Exit Points: Based on technical indicators and market trends.

Risks of Momentum Trading

  • Market Volatility: Sudden reversals can lead to significant losses.
  • Fast paced: Requires constant market monitoring and quick decision-making.

Key Indicators Used in Momentum Trading

Momentum traders often rely on fundamental data like news or technical indicators events to make informed decisions, such as:

  • Moving Averages: Identify trend directions and potential reversal points.
  • Relative Strength Index (RSI): Measures the speed and change of price movements.
  • MACD (Moving Average Convergence Divergence): Shows the relationship between two moving averages.

What is a Momentum Scanner?

A momentum scanner is a specialized tool that helps traders identify stocks exhibiting significant price movements. These scanners analyze vast amounts of market data in real-time to alert traders of potential trading opportunities based on predefined criteria.

How Does a Momentum Scanner Help Traders?

  • Real-Time Monitoring: Continuously scans the market for stocks breaking new highs or lows.
  • Customizable Filters: Allows traders to set specific criteria based on their strategies.
  • Efficiency: Saves time by automating the scanning process, enabling traders to focus on analysis and execution.
  • Alerts and Notifications: Provides instant alerts when a stock meets the momentum criteria.

Why is a Momentum Scanner Essential?

In today's fast-paced markets, opportunities can arise and disappear within minutes. A momentum scanner ensures that traders:

  • Never Miss Opportunities: Stay ahead by identifying movements as they happen.
  • React Quickly: Make timely decisions to enter or exit positions.
  • Improve Accuracy: Rely on data-driven insights rather than guesswork.

Introducing Argus Momentum Scanner

Argus is a state-of-the-art momentum scanner designed to empower traders with real-time market insights. By integrating advanced scanning technology with real-time news feeds, Argus provides a comprehensive platform for identifying and analyzing momentum in the stock market.

Key Features of Argus

  • Real-Time Market Monitoring: Continuously scans for stocks making significant moves.
  • News Integration: Correlates price movements with relevant news articles.
  • Customizable Alerts: Set personalized thresholds and filters to match your trading strategy.
  • Performance Tracking: Monitor daily top gainers and losers in the market.
  • User-Friendly Interface: Intuitive design for seamless navigation and analysis.

Advantages of Using Argus

  • Informed Decision-Making: Understand the reasons behind market movements.
  • Time Efficiency: Argus acts as your eyes on the market, saving valuable time.
  • Competitive Edge: Stay ahead of other traders with instant alerts and data.
  • Simplicity: Suitable for both novice and experienced traders.

Who Benefits from Argus?

Argus is designed to cater to a wide range of traders and investors. Here's how different types of market participants can benefit:

News-Driven Traders

For traders who focus on news catalysts:

  • Instant Alerts: Receive notifications when news impacts stock prices.
  • Breaking Stories: Stay ahead with early detection of market-moving news.
  • Verification: Quick access to news sources for due diligence.

Momentum Traders

Ideal for traders who capitalize on strong directional moves:

  • Real-Time Scanning: Identify stocks making new highs or lows instantly.
  • Sustained Momentum: Find stocks with continuous price movements.
  • Catalyst Insight: Understand the drivers behind the momentum.

Busy Professionals

Essential for those who cannot monitor the market constantly:

  • Stay Updated: Keep track of significant market moves effortlessly.
  • Daily Summaries: Get quick overviews of market performance.
  • Simplified Information: Easy-to-understand explanations of movements.

Beginner Traders

Great for those new to trading and looking to learn:

  • Educational Resources: Learn about momentum trading strategies.
  • User-Friendly Interface: Easily correlate a market movement with the reason behind it.
  • Simple to use: Simple to understand data, all automatically available on the same page.

Experienced Traders

Enhance existing strategies with advanced tools:

  • Advanced Filters: Customize scans to match complex strategies.
  • Fast Data: Access the necessary information, fast.
  • Efficiency: Streamline your workflow with integrated tools.

Membership Options

Argus is available for Free, with more advanced and accurate tools for Gold members.

Free Membership Features

Get started with basic access to market movements:

  • 1-minute delayed data updates
  • Approximated data
  • Basic new high/low alerts
  • Standard news integration
  • Daily movement summary
  • Limited alert frequency

Gold Membership Advantages

Unlock premium features for maximum market awareness:

  • Real-time data and instant alerts
  • Enhanced precision data
  • Customizable alert thresholds
  • Advanced filtering options
  • Premium support
  • No advertisements

Tips for Effective Use of Argus

Maximizing the Scanner's Potential

  • Pre-Market Preparation: Monitor pre-market news and movements to plan your trading day.
  • Leverage News Links: Use integrated news to verify and understand movement catalysts quickly.
  • Focus on Repeated Alerts: Pay attention to stocks making multiple new highs or lows, indicating stronger trends.
  • End-of-Day Analysis: Review daily summaries to identify patterns and refine your strategy.

Advanced Strategies for Gold Members

  • Customize Alerts: Set specific thresholds that align with your trading style and risk tolerance.
  • Utilize Advanced Filters: Focus on stocks within certain price ranges, volumes, or market caps.
  • Reduce Noise: Use filtering options to eliminate irrelevant data and concentrate on high-potential opportunities.

General Best Practices

  • Stay Disciplined: Stick to your trading plan and avoid impulsive decisions.
  • Manage Risk: Always use stop-loss orders and never risk more than you can afford to lose.
  • Continuous Learning: Keep updating your knowledge about market trends and trading strategies.

Understanding the Alerts

Argus provides detailed alerts to help you make informed decisions. Each alert includes:

  • Symbol: The stock's trading ticker symbol.
  • Alert Frequency: The number of significant moves the stock has made today.
  • Price Data: Current price and/or percentage change, and price movement direction.
  • Volume Information: The total trading volume for the day.
  • News Links: Direct links to news articles relevant to the stock's movement.

Interpreting the Alerts

  • High Alert Frequency: Indicates sustained momentum, consider investigating further, be careful when the value becomes too high.
  • Significant Price Change: Large percentage changes between alerts may present trading opportunities or risks.
  • Volume Spikes: Increased volume can confirm the strength of a price movement. Slowing volume may indicate a reversal.
  • Relevant News: News events can provide context and help predict future movements.

Important Information About Data Accuracy

While Argus strives to provide accurate and timely information, it's essential to understand the limitations:

  • Data Delays for Free Members: Data is delayed by approximately 1 minute and may not reflect current market prices.
  • Approximated Data: Calculations are based on available data and may not be exact.
  • Algorithmic News Correlation: News links are generated automatically and may not capture all relevant information.
  • Verification Needed: Always cross-reference data with your trading platform or other reliable sources.

Benefits of Gold Membership for Data Accuracy

  • Real-Time Data: Access to real-time market information.
  • Enhanced Precision: More accurate calculations and data points.
  • Advanced Features: Additional tools to refine your trading strategy.

Important Notice: Argus is designed as an informational tool to assist in identifying potential market opportunities. The data and information provided are for informational purposes only and should not be construed as financial advice or trading recommendations.

Key Points to Consider

  • Verification Required: Always verify movements and news through multiple sources before making trading decisions.
  • Market Risks: Trading stocks carries significant risks, including the potential loss of capital.
  • Not a Substitute for Professional Advice: Consult with qualified financial advisors for personalized investment advice.
  • No Guarantees: While we strive for accuracy, we make no guarantees about the completeness or reliability of the information provided.
  • Past Performance: Historical data and performance do not guarantee future results.
  • Automated Correlations: News correlations are automated and may not capture all market factors affecting stock movements.
  • Responsibility: Users are responsible for their own trading decisions and should conduct thorough research.

By using Argus, you acknowledge that you understand these risks and agree to not hold the platform or its creators liable for any trading losses or damages.